Results 11 to 20 of about 270,968 (206)

Factors that Facilitate and Hinder the Comprehension of Patient Information Leaflets (PILs): A Brief Scoping Review

open access: yesFrontiers in Pharmacology, 2021
Introduction: Patient information leaflets (PILs) of medicinal products are informative documents that accompany medicines and explain their components, modes of use, interactions with other medicines, and other relevant issues.
Mariana Medina-Córdoba   +3 more
doaj   +1 more source

Neural text generation in regulatory medical writing

open access: yesFrontiers in Pharmacology, 2023
Background: A steep increase in new drug applications has increased the overhead of writing technical documents such as medication guides. Natural language processing can contribute to reducing this burden.Objective: To generate medication guides from ...
Claudia Meyer   +5 more
doaj   +1 more source

Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States

open access: yesFrontiers in Pharmacology, 2023
Pharmacogenomics, which is defined as the study of changes in the properties of DNA and RNA associated with drug response, enables the prediction of the efficacy and adverse effects of drugs based on patients’ specific genetic mutations. For the safe and
Mijin Lee   +6 more
doaj   +1 more source

Pharmacists’ Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation

open access: yesPharmacy, 2022
The “breakthrough therapy” designation (BTD) is a recent mechanism implemented by the United States Food and Drug Administration (FDA) to expedite access to drugs that address unmet needs.
Megan C. Herink   +4 more
doaj   +1 more source

Community Labeling: Former Drug Convicts Become Drug Convicts Again

open access: yesDigital Press Social Sciences and Humanities, 2023
This research was motivated by the discovery of information about ex-drug convicts at Class IIB Padang prison who returned to drug convicts after repeating the same incident.
Mira Hasti Hasmira, Suhai Ratu Rahmi
doaj   +1 more source

Do asian patients require only half of the clozapine dose prescribed for caucasians? A critical overview

open access: yesIndian Journal of Psychological Medicine, 2020
Since 1997, studies have found that Asians need lower clozapine doses than Caucasians. Caucasians with average clozapine metabolism may need from 300 to 600 mg/day to reach the therapeutic range (350 ng/ml). Thus, serum clozapine concentration-to-dose (C/
Jose de Leon   +12 more
doaj   +1 more source

Impact of Drug Safety Warnings and Cost-Sharing Policies on Osteoporosis Drug Utilization in Spain: A Major Reduction But With the Persistence of Over and Underuse. Data From the ESOSVAL Cohort From 2009 to 2015

open access: yesFrontiers in Pharmacology, 2019
Background: Recent studies in several countries show a significant decrease in the consumption of osteoporosis drugs from a peak around 2009, mainly attributed to bisphosphonate safety warnings issued by regulatory agencies on jaw osteonecrosis, atypical
Isabel Hurtado-Navarro   +11 more
doaj   +1 more source

Guessability of U.S. pharmaceutical pictograms in Iranian prospective users

open access: yesPharmacy Practice, 2020
Objective: This study examined the gueassability of US pharmaceutical pictograms as well as associated demographic factors and cognitive design features among Iranian adults. Methods: A total of 400 participants requested to guess the meaning of 53 US
Mahnaz Saremi   +2 more
doaj   +1 more source

Real-World Amount of Clotting Factor Concentrates Dispensed and Annual Medical Expenditures for Japanese Patients with Hemophilia B

open access: yesJournal of Blood Medicine, 2023
Katsuyuki Fukutake,1,2 Kanae Togo,3 Linghua Xu,3 Leona E Markson,4 José Maria Jimenez Alvir,5 Ian Winburn,6 Toshiyuki Karumori3 1Laboratory Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan; 2Department of Blood Coagulation Diseases, Ogikubo ...
Fukutake K   +6 more
doaj  

Cardiovascular Drug Labeling: Do They Have Information on Necessary Precautions for Older People? [PDF]

open access: yesGeriatrics, Gerontology and Aging
OBJECTIVE: To analyze the existence of information on drug labeling intended for health professionals on the precaution of cardiovascular drugs use in older people.
Lucas Oliveira Marques   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy